子宫肌瘤科普网 | Myoma.net
基于循证医学证据的子宫肌瘤科普平台。提供专业、温暖、易懂的健康知识。
关于子宫肌瘤 (About Uterine Fibroids)
子宫肌瘤是子宫平滑肌细胞异常增殖形成的良性肿瘤,是女性最常见的良性肿瘤。中国70万人群研究显示,45-49岁女性患病率高达30.3%。绝大多数子宫肌瘤为良性,恶变率极低(<0.5%)。
Uterine fibroids are benign tumors formed by abnormal proliferation of uterine smooth muscle cells. They are the most common benign tumors in women. A Chinese population study of 695,848 women shows peak prevalence of 30.3% at ages 45-49.
症状 (Symptoms)
月经量增多、经期延长、盆腔压迫感、尿频、便秘、腰痛、不孕等。约50%的子宫肌瘤患者无明显症状。
治疗方案 (Treatment Options)
- 观察等待 - 无症状肌瘤可定期随访
- 药物治疗 - GnRH拮抗剂(Elagolix, Relugolix, Linzagolix)
- 微无创治疗 - HIFU高强度聚焦超声、微波消融、射频消融
- 微创手术 - 腹腔镜/宫腔镜肌瘤切除术、单孔腹腔镜、vNOTES
- 子宫动脉栓塞术 (UAE)
常见问题 (FAQ)
- 子宫肌瘤会癌变吗?
- 子宫肌瘤恶变为子宫肉瘤的概率极低,约0.1%-0.5%。
- 所有子宫肌瘤都需要手术吗?
- 不是。手术指征基于症状,无症状肌瘤可以观察。
- What are uterine fibroids?
- Uterine fibroids are benign tumors of the uterine smooth muscle, the most common benign tumors in women.
最新研究 (Research Updates - July 2026)
- Contemporary Management of Uterine Fibroids: A Qualitative Synthesis of 97 Studies - Journal of Clinical Medicine
- GnRH Antagonists for Fibroids and Adenomyosis: Current Evidence - Expert Opinion on Pharmacotherapy
- Single-Port vs Multi-Port Laparoscopic Myomectomy: RCT of 146 patients - Journal of Investigative Surgery
- TDO2 Inhibition: A Novel Non-Hormonal Therapeutic Target - Clinical Science
- Robotic Single-Port vNOTES Hysterectomy: First European Cases - Surgical Endoscopy
- EP-OS Network in Uterine Fibroids Pathogenesis - Redox Report
- Global Uterine Fibroid Burden Epidemiology (1990-2021) - Frontiers in Reproductive Health
联系我们:https://myoma.net | 中国妇产科网